Tempest Therapeutics, Inc. (TPST) › Net IncomeTempest Therapeutics, Inc. (TPST) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$13.51M2013: -$29.04M2014: -$49.52M2015: -$73.22M2016: -$82.26M2017: -$84.58M2018: -$27.19M2019: -$44.57M2020: -$19.21M2021: -$28.30M2022: -$35.71M2023: -$29.49M2024: -$41.84M2025: -$26.26M-$26.26M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$26.26M+37.2%2024-$41.84M-41.9%2023-$29.49M+17.4%2022-$35.71M-26.2%2021-$28.30M-47.3%2020-$19.21M+56.9%2019-$44.57M-63.9%2018-$27.19M+67.8%2017-$84.58M-2.8%2016-$82.26M-12.3%2015-$73.22M-47.9%2014-$49.52M-70.5%2013-$29.04M-115.0%2012-$13.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share